Etiqueta: stem cell therapy
-
Fat Stem Cells are not affected by weight or age
Mojallal et al. Aesthetic Plast Surg. Fat represents a potent source of autologous stem cells. Historically, the majority of research using autologous stem cells involved stem cells collected from the bone marrow. This source is associated with a painful extraction procedure and relatively low concentrations of mesenchymal stem cells. In contract, mini-liposuctions represent a less…
-
New Stem Cell Therapy Guidelines Approved in Texas
The Texas Medical Board has approved new rules regulating adult stem cell therapies similar to the ones used to treat Governor Rick Perry last summer, the Associated Press (AP) reported on Friday. The rules were drafted by the state board, which licenses and disciplines doctors, at the request of Houston’s Dr. Stanley Jones, the same…
-
«The fight to walk» – spinal cord injury patient improving after stem cell therapy in Panama
Published March 31, 2012 By Sue Guinn Legg – Press Staff Writer Daniel Leonard is doing all he can to walk again, and after a recent course of stem cell treatment he’s as close as he has been since a few months after the 2005 injury that put him a wheelchair. He was 22 years…
-
Great Day in Ft. Worth for Stem Cell Team
Saturday, March 31 was the annual MS Walk in Ft Worth. This year, thanks to the Stem Cell Institute and some of the area stem cell patients, several of us MS sufferers and stem cell patients met for the Walk. Here’s a picture of several of us who have been to Panama, or Costa Rica,…
-
Stemedica Treats First Patient with Ischemic Allogeneic Mesenchymal Stem Cells
Stemedica Cell Technologies Press Release The San Diego stem cell company Stemedica Cell Technologies, Inc reported treatment of its first patient as part of a 35 patient clinical trial in stroke patients. The study uses bone marrow stem cells that have been preconditioned with hypoxia and used in a non-matched manner. The trial is being…
-
Medistem Signs Exclusive Worldwide License With Yale University for Treatment of Type 1 Diabetes Using Stem Cells
Acquisition of Intellectual Property and Data Leads to Expansion of Medistem Therapeutic Pipeline SAN DIEGO, CA, Mar 07, 2012 (MARKETWIRE via COMTEX) — Medistem Inc. (pinksheets:MEDS) and Yale University have signed an exclusive worldwide licensing agreement covering the generation of pancreatic islets from stem cells such as the Endometrial Regenerative Cell (ERC). These pancreatic islets…
-
Medistem Inc. to Add Kidney and Lung Failure to Clinical Trials of Endometrial Regenerative Cells (ERC) Stem Cells in Russia
SAN DIEGO, CA and PORTLAND, OR, Mar 05, 2012 (MARKETWIRE via COMTEX) — Medistem Inc. (pinksheets:MEDS), in partnership with its Russian licensee, ERCell, announced the signing of a letter of intent* to begin clinical trials using Medistem’s Endometrial Regenerative Cells (ERC) stem cells for renal, lung and peripheral artery disease. Trials will be conducted in…
-
Ischemic Stroke Recovery May Be Improved Using Stem Cell Therapy
At the American Heart Association’s International Stroke Conference in New Orleans, two studies suggested that stem cell therapy improves functional recovery following subacute ischemic stroke and may aid in regenerative therapy. One hundred and twenty subacute ischemic stroke patients were treated with mononuclear bone marrow-derived stem cells. Patients ranged in age from eighteen to seventy…
-
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du MQ, Luan SL, Altmann DR, Thompson AJ, Compston A, Scott MA, Miller DH, Chandran S. Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. Abstract BACKGROUND: More than half of patients with multiple sclerosis have progressive disease characterised by accumulating disability. The…